Microbot Medical Inc. (MBOT)
收市後：
| 前收市價 | 0.9600 |
| 開市 | 0.9400 |
| 買盤 | 0.9744 x 200 |
| 賣出價 | 1.0100 x 400 |
| 今日波幅 | 0.9303 - 0.9999 |
| 52 週波幅 | 0.8600 - 4.3700 |
| 成交量 | |
| 平均成交量 | 100,654 |
| 市值 | 14.377M |
| Beta 值 (5 年，每月) | 1.65 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -1.0500 |
| 業績公佈日 | 2024年5月15日 - 2024年5月20日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 7.00 |
ZacksMicrobot Medical (MBOT) Files IDE to Start Human Clinical Study
Microbot Medical (MBOT) files an IDE with the FDA, approval of which will enable the company to proceed with its human clinical study in the United States.
InvestorPlace3 Stocks at the Forefront of Medical Robotics
Every now and then, speculation – within carefully defined limits – may be appropriate, which brings us to the case for medical robotics stocks to buy. Sure, you can gamble on just about anything these days and a non-zero probability exists for their upside. During the post-pandemic period, we’ve seen everything from video game retailers to private prisons skyrocket via pure hypothesizing in action. However, medical robotics stocks offer a genuinely viable (albeit risky) path to significant mark
InvestorPlace3 Undervalued Penny Stocks to Buy for Multi-Bagger Returns
The stock market can provide investors with an unpredictable and thrilling journey, filled with both excitement and anticipation. This article will delve into the peak of that exhilaration – penny stocks, and particularly high return penny stocks which may be undervalued relative to their future potential. These lesser-known stocks have the potential for significant returns. Bold investors might find them particularly interesting. Penny stocks do carry some risk due to their smaller market cap a
